Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients

The aim of this study was to assess whether a combination of gemcitabine (GEM) with either paclitaxel (PTX) or vinorelbine (VNR) could be more effective than GEM or PTX alone in elderly or unfit advanced non-small-cell lung cancer (NSCLC) patients. A total of 264 NSCLC patients aged >70 years wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Comella, P, Frasci, G, Carnicelli, P, Massidda, B, Buzzi, F, Filippelli, G, Maiorino, L, Guida, M, Panza, N, Mancarella, S, Cioffi, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409832/
https://www.ncbi.nlm.nih.gov/pubmed/15266334
http://dx.doi.org/10.1038/sj.bjc.6602011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409832/
https://www.ncbi.nlm.nih.gov/pubmed/15266334
http://dx.doi.org/10.1038/sj.bjc.6602011

Ejemplares similares